TFGT
REGN icon

TS Financial Group (TSFG)’s Regeneron Pharmaceuticals REGN Stock Holding History

TS Financial Group (TSFG)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51K Buy
81
+6
+8% +$4.08K 0.01% 371
2026
Q1 		$58K Hold
75
– – 0.01% 331
2025
Q4 		$58K Sell
75
-17
-18% -$11.5K 0.01% 315
2025
Q3 		$52K Hold
92
– – 0.01% 334
2025
Q2 		$48K Buy
92
+17
+23% +$9.49K 0.01% 335
2025
Q1 		$48K Sell
75
-15
-17% -$10.3K 0.01% 317
2024
Q4 		$64K Hold
90
– – 0.01% 265
2024
Q3 		$95K Hold
90
– – 0.02% 218
2024
Q2 		$95K Hold
90
– – 0.02% 204
2024
Q1 		$87K Hold
90
– – 0.02% 207
2023
Q4 		$79K Hold
90
– – 0.02% 231
2023
Q3 		$74K Hold
90
– – 0.03% 241
2023
Q2 		$65K Hold
90
– – 0.02% 251
2023
Q1 		$74K Hold
90
– – 0.03% 230
2022
Q4 		$65K Buy
90
+55
+157% +$40.6K 0.03% 248
2022
Q3 		$24K Sell
35
-5
-13% -$3.15K 0.01% 382
2022
Q2 		$24K Hold
40
– – 0.01% 383
2022
Q1 		$28K Hold
40
– – 0.01% 368
2021
Q4 		$25K Hold
40
– – 0.01% 393
2021
Q3 		$24K Hold
40
– – 0.01% 409
2021
Q2 		$22K Hold
40
– – 0.01% 418
2021
Q1 		$19K Sell
40
-16
-29% -$7.79K 0.01% 379
2020
Q4 		$27K Sell
56
-63
-53% -$34K 0.01% 331
2020
Q3 		$67K Buy
119
+56
+89% +$34K 0.04% 187
2020
Q2 		$39K Sell
63
-8
-11% -$4.54K 0.03% 252
2020
Q1 		$35K Sell
71
-165
-70% -$68.1K 0.03% 235
2019
Q4 		$89K Buy
236
+202
+594% +$68K 0.07% 154
2019
Q3 		$9K Buy
34
+4
+13% +$1.18K 0.01% 432
2019
Q2 		$9K Buy
30
+1
+3% +$333 0.01% 426
2019
Q1 		$12K Buy
+29
New +$11.9K 0.01% 369

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

TS Financial Group (TSFG)'s REGN Position: Q2 2026 in Review

TS Financial Group (TSFG) increased its Regeneron Pharmaceuticals (REGN) stake by 8% in Q2 2026, buying an estimated $4.08K and bringing the position to 81 shares worth $51K. The position accounts for 0.01% of the portfolio, ranked #371.

TS Financial Group (TSFG) first reported a position in REGN in Q1 2019 and has held it in 30 quarters since. The position peaked at $95K in Q3 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • TS Financial Group (TSFG) held 81 shares of Regeneron Pharmaceuticals worth $51K as of Q2 2026.
  • TS Financial Group (TSFG) bought 6 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.08K.
  • Regeneron Pharmaceuticals made up 0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #371 holding.
  • TS Financial Group (TSFG) first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 30 quarters since.
  • TS Financial Group (TSFG)'s Regeneron Pharmaceuticals position peaked at $95K in Q3 2024.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.